An APA and SAMHSA Initiative

Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Person-First Language
Our Tools
SMI Adviser App My Mental Health Crisis Plan Clozapine Dose Planner LAI Conversion Tool
About Us
Calendar
Contact

Search for:

∕
Knowledge Base
∕
Clozapine as part of the treatment plan

Topic: Clozapine as part of the treatment plan

Knowledge Base (Individuals+Families)

33 result(s) found.

What can I do if it is difficult or risky to start a patient on clozapine? Should patients be started on clozapine in the hospital?
What are the issues regarding families and caregivers supporting clozapine treatment?
Are there any contraindications or reasons a patient cannot be considered for clozapine? Can a patient with myocarditis or severe neutropenia be rechallenged and take clozapine again?
What is Benign Ethnic Neutropenia and does it relate to low clozapine white counts?
What should be done if the clozapine treatment of a patient is interrupted, or they do not take their clozapine for a few days or longer?
How do I interpret clozapine or norclozapine blood, serum or plasma levels, what do these mean?
Clozapine Blood Count Monitoring
When to use clozapine
Vision side effects of clozapine
How does one dose or titrate clozapine dosage when starting on this medication?
Sedation Side Effect with Clozapine
Myocarditis Side Effect of Clozapine
Constipation Side Effect of Clozapine
Clozapine Seizure Side Effect
Orthostatic hypotension, bradycardia, and syncope side effects of clozapine
Clozapine Tachycardia Side Effect
Salivation Side Effect with Clozapine
How does clozapine work and how is it different from other medications?
Why is clozapine not the first medication chosen to treat schizophrenia for everyone?
Which patients are eligible for clozapine?
Can clozapine cause problems with urine or urination, such as incontinence or enuresis?
Is there anything I should know about smoking, tobacco or nicotine and clozapine?
I’ve heard about close lab monitoring with clozapine. What happens if the ANC level gets low when someone is taking clozapine?
What metabolic monitoring is appropriate when patients are taking clozapine? Should we monitor weight, labs or vital signs?
What are some online resources to help me learn about clozapine?
Clozapine Brochure
What is known about use of clozapine for schizophrenia in children and adolescents (people younger than 18 years old)?
Is clozapine more effective than other antipsychotic medications in individuals with treatment-resistant psychosis?
What can be done if a patient taking clozapine is travelling to a foreign country?
Ask About Clozapine – Informational Handout
Clozapine REMS Program Updates
Talking to Individuals and Families About Clozapine
Clozapine Expert Panel

Join our #MissionForBetter now

Sign up for our newsletter. We’ll let you know about new resources, education, and more.

Saved Posts

Administered by

Funded by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2023 American Psychiatric Association. All rights reserved.

X

Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset